(Q34609461)

3 August 2017

1 reference

title

Immunoregulatory effects of indoleamine 2, 3-dioxygenase in transplantation (English)

1 reference

3 August 2017

Lining Jia

1

1 reference

PubMed ID

19565672

3 August 2017

Puxun Tian

series ordinal

2

1 reference

PubMed ID

19565672

3 August 2017

Chenguang Ding

series ordinal

3

1 reference

3 August 2017

1 May 2009

1 reference

3 August 2017

Transplant Immunology

1 reference

3 August 2017

21

1 reference

3 August 2017

1

1 reference

3 August 2017

18-22

1 reference

IDO expression by dendritic cells: tolerance and tryptophan catabolism

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

CTLA-4-Ig regulates tryptophan catabolism in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Modulation of tryptophan catabolism by regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Prevention of allogeneic fetal rejection by tryptophan catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Creating immune privilege: active local suppression that benefits friends, but protects foes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

The immunoregulatory role of IDO-producing human dendritic cells revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

T cell apoptosis by tryptophan catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Tryptophan catabolism generates autoimmune-preventive regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

A high-affinity, tryptophan-selective amino acid transport system in human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Decreased protein nitration in macrophages that overexpress indoleamine 2, 3-dioxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Role of IFNγ in Allograft Tolerance Mediated by CD4+CD25+Regulatory T Cells by Induction of IDO in Endothelial Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

CTLA4Ig: bridging the basic immunology with clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Costimulation blockade with belatacept in renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Post-translational Regulation of Human Indoleamine 2,3-Dioxygenase Activity by Nitric Oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Nonviral gene delivery with indoleamine 2,3-dioxygenase targeting pulmonary endothelium protects against ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Suppression of islet allogeneic immune response by indoleamine 2,3 dioxygenase-expressing fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Local expression of IDO, either alone or in combination with CD40Ig, IL10 or CTLA4Ig, inhibits indirect xenorejection responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Suppression of cytotoxic and proliferative xenogeneic T-cell responses by transgenic expression of indoleamine 2,3-dioxygenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Tolerogenic dendritic cells transferring hyporesponsiveness and synergizing T regulatory cells in transplant tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Gene delivery of indoleamine 2,3-dioxygenase prolongs cardiac allograft survival by shaping the types of T-cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Blocking indoleamine dioxygenase activity early after rat liver transplantation prevents long-term survival but does not cause acute rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

Skin cells, but not T cells, are resistant to indoleamine 2, 3-dioxygenase (IDO) expressed by allogeneic fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.01.004

10.1016/J.TRIM.2009.01.004

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

19565672